Cogent Biosciences Income Statement (2017-2021) | COGT

Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021
Revenue & cost
Revenue 1.83M2.08M2.33M2.12M2.22M1.67M2.04M3.81M3.05M3.14M1.02M15.29M7.03M0.53M0.31M
Operating items
Research & Development 6.95M7.14M8.18M7.56M8.14M9.13M10.25M10.77M12.40M10.62M10.34M10.35M9.50M5.13M5.00M6.11M
Selling, General & Administrative 0.94M0.97M1.32M1.44M1.06M1.98M2.37M2.04M2.49M3.06M2.72M2.69M3.67M2.80M5.60M5.35M
Other Operating Expenses 46.91M
Operating Expenses 7.90M8.11M9.50M9.00M9.21M11.11M12.62M12.81M14.89M13.68M13.06M13.05M13.17M7.93M57.51M11.46M
Operating Income -6.07M-6.03M-7.17M-6.88M-6.99M-9.44M-10.58M-9.00M-11.84M-10.54M-12.04M2.24M-6.14M-7.40M-57.20M-11.46M
EBIT -6.07M-6.03M-7.17M-6.88M-6.99M-9.44M-10.58M-9.00M-11.84M-10.54M-12.04M2.24M-6.14M-7.40M-57.20M-11.46M
Non-operating items
Interest & Investment Income 0.09M0.10M0.10M0.10M0.08M0.26M0.41M0.41M0.15M0.03M0.03M0.06M0.05M0.00M0.02M0.07M
Other Non Operating Income 0.04M0.07M0.07M0.09M0.17M0.16M0.00M-0.01M0.08M-0.00M0.24M0.54M
Non Operating Income 0.13M0.17M0.17M0.19M0.25M0.42M0.41M0.40M0.15M0.03M0.11M0.06M0.05M0.01M7.22M0.12M
Net income details
EBT -5.98M-5.94M-7.07M-6.78M-6.91M-9.18M-10.17M-8.60M-11.69M-10.52M-12.01M2.30M-6.09M-7.40M-57.18M-11.38M
Profit After Tax -5.94M-5.86M-7.00M-6.69M-6.74M-9.02M-10.17M-8.61M-11.69M-10.52M-11.92M2.30M-6.09M-7.39M-49.98M-11.34M
Income from Continuing Operations -5.98M-5.94M-7.07M-6.78M-6.91M-9.18M-10.17M-8.60M-11.69M-10.52M-12.01M2.30M-6.09M-7.40M-57.18M-11.38M
Consolidated Net Income -5.98M-5.94M-7.07M-6.78M-6.91M-9.18M-10.17M-8.60M-11.69M-10.52M-12.01M2.30M-6.09M-7.40M-57.18M-11.38M
Income towards Parent Company -5.98M-5.94M-7.07M-6.78M-6.91M-9.18M-10.17M-8.60M-11.69M-10.52M-12.01M2.30M-6.09M-7.40M-57.18M-11.38M
Preferred Dividend Payments 0.02M0.02M0.02M0.02M0.02M
Net Income towards Common Stockholders -5.96M-5.88M-7.02M-6.71M-6.75M-9.02M-10.17M-8.61M-11.69M-10.52M-11.92M2.30M-6.09M-7.40M-57.18M-11.38M
Additional items
EPS (Basic) -0.58-0.58-0.69-0.66-0.66-0.31-0.34-0.29-0.39-0.34-1.560.07-0.81-0.95-5.07-8.61
Shares Outstanding (Weighted Average) 7.40M7.40M7.46M7.47M7.50M7.52M7.53M7.67M7.67M7.65M7.79M9.57M11.34M37.19M38.41M39.85M
Shares Outstanding (Diluted Average) 38.44M39.85M
EBITDA -5.95M-5.87M-6.98M-6.68M-6.73M-9.03M-10.18M-8.59M-11.68M-10.51M-11.92M2.30M-6.09M-7.39M-49.98M-11.34M